secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2023-02-01T23:59:59+00:00
Accession:  0001005286-23-000032
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore restates FY2022 and Q1 FY2023 financials due to impairment errors in Curation Foods
--------------------------------------------------------------------------------

- Audit Committee determined prior financials (year ended May 29, 2022 and quarter ended Aug 28, 2022) are unreliable due to non-cash impairment charge errors.
- Errors relate to Curation Foods business; company expects to record a material weakness in internal control over financial reporting.
- Restatement not expected to adversely affect operations, liquidity, or Lifecore/Other segment data.
- Company will file amended 10-K/A and 10-Q/A; no specific dollar impact disclosed yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000032/0001005286-23-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000032/lndc-20230131.htm
  HTML page:      https://secwatch.observer/filing/0001005286-23-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer